Brian Siegel, MD
Surgical Critical Care · Somerville, NJNPI 1477555977
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,784 of the $6,082 with a category attached, or 78.7%. 24 manufacturers reported payments, led by Edwards Lifesciences at 27.4% of the total. Reporting peaked in 2019 at $1,781 and has fallen 71.3% since, to $512 in 2025.
Across 72 payments — averaging $84.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- La Jolla Pharmaceutical Company$826
- AstraZeneca$819
- Shionogi Inc$455
- Inari Medical, Inc.$374
- Gilead$344
- plus $2K from 18 others
What the payments were for
- Travel & lodging$1,29821%
- Food & beverage$4,78479%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 8 | $1,664 |
| La Jolla Pharmaceutical Company | 9 | $826 |
| AstraZeneca(2 entities) | 7 | $819 |
| Shionogi Inc | 4 | $455 |
| Inari Medical, Inc. | 2 | $374 |
| Gilead | 3 | $344 |
| Pfizer | 15 | $208 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $207 |
| Mallinckrodt Hospital Products Inc. | 2 | $160 |
| KCI USA, Inc. | 2 | $156 |
| Johnson & Johnson | 1 | $148 |
| CSL Behring | 2 | $135 |
| Haemonetics Corporation | 1 | $121 |
| Polarityte, Inc. | 1 | $110 |
| AbbVie | 1 | $110 |
| Kerecis Limited | 1 | $57 |
| Mindray DS USA, Inc. | 2 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $32 |
| UCB, Inc. | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Abiomed | 1 | $16 |
| Chiesi USA, Inc. | 1 | $16 |
| Merck | 1 | $14 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$704
- GIAPREZA$653
- Fetroja$455
- FLOWTRIEVER CATHETER, S$374
- CT THROMBECTOMY SYSTEM KIT$374
- Veklury$250
- XARELTO$148
- TERLIVAZ$147
- TEG6s HEMOSTASIS SYSTEM$121
- PREVENA$119
- ABTHERA$119
- VAC VERAFLO CLEANSE CHOICE$119
- VAC VERAFLO$119
- Kcentra$117
- SkinTE$110
- AVYCAZ$110
- XIFAXAN$104
- RELISTOR$103
How this compares
$6,082 in reported general payments places this provider in the 80th percentile of 45 surgical critical care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical critical care in Somerville
- Hesham AhmedNew Brunswick$164K
- Maurizio MigliettaTeaneck$131K
- Ju Lin WangCamden$22K
- Saraswati DayalHackensack$19K
- Sanjeev KaulHackensack$17K
- Steven JohnsonPennington$9K
- Leahna CooneyPennington$6K
- Douglas JamesHackensack$6K
- Emad Nourollah-ZadehNew Brunswick$4K
- Anuradha KarNew Brunswick$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.